National Aspergillosis Centre - INCAS trial
@nacincas
INCAS is a Phase2 RCT (NCT05653193): adjunctive interferon gamma to treat chronic pulmonary aspergillosis
Based at @MFT_NAC (@MFTnhs), funded by @NIHRresearch
ID: 1573224275502370819
23-09-2022 08:14:41
114 Tweet
51 Followers
177 Following
🥳🎉We just recruited our first patient for the National Aspergillosis Centre - INCAS trial trial! Now we just need another 49... 💉NCT05653193: adjunctive #IFNγ for chronic #pulmonary #aspergillosis ➡️bit.ly/462RlmX #respiratory #clinicaltrials #immunology NIHR CRN Greater Manchester #whywedoresearch MFT Research and Innovation